Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Biomaterials
|
January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.
Journal of Neurotrauma
|
July 18, 2013
A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury
Robert G Grossman, Michael G Fehlings, Ralph F Frankowski, et al.
Journal of Clinical Pharmacology
|
April 28, 2021
Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent
Ashley Nguyen, Diana S-L Chow, Lei Wu, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
An end-to-end workflow for non-destructive 3D pathology
Kevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Nature Protocols
|
January 24, 2024
An end-to-end workflow for nondestructive 3D pathology
Kevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Cell
|
May 10, 2024
Analysis of 3D pathology samples using weakly supervised AI
Andrew H Song, Mane Williams, Drew F K Williamson, et al.
Topics in Spinal Cord Injury Rehabilitation
|
June 30, 2025
Exploring the Landscape of Biomarkers in Spinal Cord Injury
Paulina S Scheuren, Bethany R Kondiles, Angela R Filous, et al.
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
Deep-learning triage of 3D pathology datasets for comprehensive and efficient pathologist assessments
Gan Gao, Renao Yan, Andrew H Song, et al.
Journal of Neurotrauma
|
June 6, 2023
Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial
Michael G Fehlings, Ali Moghaddamjou, James S Harrop, et al.
Ebiomedicine
|
July 25, 2025
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique
Michael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Biomaterials
|
January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.
Journal of Neurotrauma
|
July 18, 2013
A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury
Robert G Grossman, Michael G Fehlings, Ralph F Frankowski, et al.
Journal of Clinical Pharmacology
|
April 28, 2021
Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent
Ashley Nguyen, Diana S-L Chow, Lei Wu, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
An end-to-end workflow for non-destructive 3D pathology
Kevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Nature Protocols
|
January 24, 2024
An end-to-end workflow for nondestructive 3D pathology
Kevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Cell
|
May 10, 2024
Analysis of 3D pathology samples using weakly supervised AI
Andrew H Song, Mane Williams, Drew F K Williamson, et al.
Topics in Spinal Cord Injury Rehabilitation
|
June 30, 2025
Exploring the Landscape of Biomarkers in Spinal Cord Injury
Paulina S Scheuren, Bethany R Kondiles, Angela R Filous, et al.
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
Deep-learning triage of 3D pathology datasets for comprehensive and efficient pathologist assessments
Gan Gao, Renao Yan, Andrew H Song, et al.
Journal of Neurotrauma
|
June 6, 2023
Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial
Michael G Fehlings, Ali Moghaddamjou, James S Harrop, et al.
Ebiomedicine
|
July 25, 2025
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique
Michael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.
Page
of 9